Description:
LOWE OCULOCEREBRORENAL SYNDROME; OCRL
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Ophthalmologic Disorders |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
2 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
|
Remarks |
At risk (50%); 46,XY; a brother was affected; pedigree shows multiple affected individuals |
Madhivanan K, Ramadesikan S, Hsieh WC, Aguilar MC, Hanna CB, Bacallao RL, Aguilar RC, Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins Human molecular genetics: 2020 |
PubMed ID: 32391547 |
|
Luo N, West CC, Murga-Zamalloa CA, Sun L, Anderson RM, Wells CD, Weinreb RN, Travers JB, Khanna H, Sun Y, OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome Human molecular genetics21:3333-44 2012 |
PubMed ID: 22543976 |
|
Coon, B.G., Mukherjee, D., Hanna, C.B., Riese II, D.J., Lowe, M., and Aguilar, R.C., Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase Hum Molec Genet18(23):4478-4491 2009 |
PubMed ID: 19700499 |
|
Allen PG, Actin filament uncapping localizes to ruffling lamellae and rocketing vesicles Nature cell biology5:972-9 2003 |
PubMed ID: 14557819 |
Passage Frozen |
2 |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|